SynGAP activators represent a category of chemical compounds designed to modulate the activity of SynGAP, a protein which is critical for synaptic function and plasticity. SynGAP, short for synaptic Ras GTPase activating protein, is an integral component of the postsynaptic density (PSD) of excitatory synapses and acts as a negative regulator of small GTPases, such as Ras and Rap, which are vital for synaptic signaling and plasticity. By accelerating the hydrolysis of GTP to GDP on these GTPases, SynGAP effectively downregulates their activity, thus playing a key role in the modulation of synaptic transmission and the fine-tuning of synaptic plasticity mechanisms such as long-term potentiation (LTP) and long-term depression (LTD).
The science behind SynGAP activators involves the enhancement of SynGAP's intrinsic activity or the promotion of its expression within neuronal cells. The activators may function by directly interacting with SynGAP, altering its conformation in a way that increases its GTPase-activating protein (GAP) activity towards its targets. Alternatively, these compounds could indirectly augment SynGAP function by upregulating its expression, stabilizing the protein, or facilitating its localization to synapses where it can exert its effects. By promoting the activity of SynGAP, these activators can help to elucidate the complex signaling pathways involved in synaptic function and contribute to our understanding of the molecular underpinnings of synaptic plasticity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Okadaic Acid is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which leads to increased phosphorylation of proteins. Increased phosphorylation of SynGAP can enhance its activity by preventing its dephosphorylation. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Forskolin is an adenylyl cyclase activator which increases intracellular cAMP levels. An increased level of cAMP can enhance SynGAP activity through the PKA-dependent pathway. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC). PKC phosphorylates SynGAP, thereby enhancing its activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $75.00 $212.00 | 18 | |
Rolipram is a PDE4 inhibitor, which results in increased cAMP levels. Like Forskolin, this can activate PKA and enhance SynGAP activity. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A sc-24000B sc-24000C | 10 µg 100 µg 500 µg 1 mg | $160.00 $750.00 $1400.00 $3000.00 | 59 | |
Calyculin A is an inhibitor of PP1 and PP2A. It enhances SynGAP activity by maintaining its phosphorylation status. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin is a calcium ionophore. It can increase calcium levels, triggering a cascade that can enhance SynGAP activity via calcium-dependent kinases. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor, which increases cytoplasmic calcium levels. This can trigger a cascade enhancing SynGAP activity. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor, which can increase the specificity of certain kinases towards SynGAP, enhancing its activity. | ||||||
KT 5720 | 108068-98-0 | sc-3538 sc-3538A sc-3538B | 50 µg 100 µg 500 µg | $97.00 $144.00 $648.00 | 47 | |
KT5720 is a potent and selective inhibitor of PKA. Despite being an inhibitor, it enhances SynGAP activity by increasing the specificity of PKA towards other substrates. | ||||||